Konomi (Beijing) Technology
AI-powered diagnostics and analysis for healthcare.
| Date | Investors | Amount | Round |
|---|---|---|---|
| investor investor investor | €0.0 | round | |
* | CNY20.0m Valuation: CNY500m | Series A | |
| Total Funding | 000k | ||
Konomi (Beijing) Technology Co., Ltd., operating as Chromai, is a high-tech enterprise founded in 2019 that develops and produces analytical and testing instruments. The company is headquartered in Beijing, China, and focuses on integrating technologies like AI, Big Data, and IoT with advanced analytical detection methods. Its primary markets include in-vitro diagnostics (IVD) for the healthcare sector, environmental protection, and scientific instruments.
Chromai's product line features a range of high-performance liquid chromatography (HPLC) and ultra-high-performance liquid chromatography (UHPLC) systems. These include the Voyager series, an automated two-dimensional liquid chromatography system for IVD that aims to simplify the diagnostic process for medical users. The company also offers the Frontier UHPLC system, the bio-inert Leaps Pro Bio system for analyzing biological molecules, and the more economical Leaps UHPLC system. By combining its hardware with AI, Chromai aims to provide simplified and efficient diagnostic and testing analysis.
Since its founding, Chromai has secured significant funding to support its growth. The company raised $14.2 million in an Early Stage Venture Capital round on June 5, 2023. Investors in the company include Huagai Capital, Tsing Stone Asset Management, Hongshan Capital Group, Suzhou Guofa Venture Capital, and YuanBio Venture Capital.
Keywords: medical diagnostics, liquid chromatography, in-vitro diagnostics, IVD, analytical instruments, AI diagnostics, medical testing technology, UHPLC systems, Big Data in healthcare, IoT medical devices, environmental testing, scientific instruments, diagnostic equipment, health technology, Beijing startup